{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:04:15Z","timestamp":1790820255964,"version":"4.1.0"},"reference-count":17,"publisher":"Cambridge University Press (CUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neonates with ductal-dependent congenital heart disease (CHD) will receive a continuous infusion of a prostaglandin E1 analogue such as alprostadil prior to surgical correction. Alprostadil can cause apnoea, which may be mitigated in practice with the use of caffeine citrate. Caffeine citrate can lead to tachyarrhythmias, which could be detrimental in this patient population. The purpose of this study was to determine if the practice of utilising caffeine citrate in neonates with ductal-dependent CHD receiving continuous alprostadil infusions is safe. In this single-centre, retrospective, cohort study of neonates admitted to the congenital heart service from November 2017 to September 2024, patients were included if they had ductal-dependent CHD and a gestational age greater than or equal to 35 weeks. Neonates that received continuous infusion of alprostadil alone were compared to those that received alprostadil in addition to caffeine citrate. The primary outcome was the frequency of sustained tachycardia during treatment. Seventy-five patients were included for review in each cohort. The median number of incidences of sustained tachycardia per patient was 7 (interquartile range 1\u201320) in the alprostadil plus caffeine citrate group and 4 (interquartile range 0\u201318) in the alprostadil alone group (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.293). Other arrhythmias during the treatment course were common and similar between each cohort. Utilising caffeine citrate was not associated with a statistically significant increased incidence of tachycardia in neonates with ductal-dependent CHD on alprostadil infusions at the University of Florida.\n                  <\/jats:p>","DOI":"10.1017\/s1047951125110901","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:02:07Z","timestamp":1784620927000},"page":"1323-1328","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Safety of caffeine citrate in neonates with Congenital Heart Disease receiving continuous infusions of alprostadil"],"prefix":"10.1017","volume":"36","author":[{"given":"Savannah L.","family":"Mace","sequence":"first","affiliation":[{"name":"University of Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"VandenBerg","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Lopez-Colon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Florida College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-6498","authenticated-orcid":false,"given":"Giles J.","family":"Peek","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Florida College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Steven","family":"Bleiweis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Florida College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9916-929X","authenticated-orcid":false,"given":"Jeffrey Phillip","family":"Jacobs","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Florida College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Philip","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Florida College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukumar Suguna","family":"Narasimhulu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Florida College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"S1047951125110901_ref2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2017-0032"},{"key":"S1047951125110901_ref13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.1.e27"},{"key":"S1047951125110901_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2024.08.020"},{"key":"S1047951125110901_ref1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3435"},{"key":"S1047951125110901_ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.842544"},{"key":"S1047951125110901_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-009-0030-4"},{"key":"S1047951125110901_ref5","first-page":"37","article-title":"Effectiveness of alprostadil for ductal patency","volume":"29","author":"Gordon","year":"2024","journal-title":"JPPT"},{"key":"S1047951125110901_ref4","first-page":"107","article-title":"The fetal circulation, continuing education in anesthesia critical care and","volume":"5","author":"Peter","year":"2005","journal-title":"Pain"},{"key":"S1047951125110901_ref7","unstructured":"7. UpToDate Inc. Alprostadil [Drug information]. Lexi-Drugs, Pediatric and Neonatal Lexi-Drugs Online, UpToDate Lexidrug. 2025. Retrieved February 7, 2025."},{"key":"S1047951125110901_ref12","unstructured":"12. UpToDate Inc. Caffeine Citrate [Drug information]. Lexi-Drugs, Pediatric and Neonatal Lexi-Drugs Online, UpToDate Lexidrug. 2025. Retrieved February 7, 2025."},{"key":"S1047951125110901_ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.64.5.893"},{"key":"S1047951125110901_ref6","doi-asserted-by":"publisher","DOI":"10.1515\/jccm-2016-0031"},{"key":"S1047951125110901_ref17","doi-asserted-by":"publisher","DOI":"10.1089\/jcr.2016.0012"},{"key":"S1047951125110901_ref11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3757"},{"key":"S1047951125110901_ref10","first-page":"235","article-title":"Caffeine citrate for the prevention of apnea associated with alprostadil infusions","volume":"25","author":"Higgins","year":"2020","journal-title":"JPPT"},{"key":"S1047951125110901_ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054065"},{"key":"S1047951125110901_ref9","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951120003297"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951125110901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:45:54Z","timestamp":1790819154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951125110901\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1047951125110901"],"URL":"https:\/\/doi.org\/10.1017\/s1047951125110901","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}